Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host Two Workshops... SMi's 6th annual ADC Conference
Partner Content Partner Content Hear from Janssen and Antikor Biopharma at SMi’s ADC Confere... Janssen and Antikor Biopharma Speak this April
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
